Copyright
©The Author(s) 2015.
World J Gastroenterol. Oct 7, 2015; 21(37): 10688-10696
Published online Oct 7, 2015. doi: 10.3748/wjg.v21.i37.10688
Published online Oct 7, 2015. doi: 10.3748/wjg.v21.i37.10688
Table 3 Acute toxicity (41 patients analyzed) n (%)
| G0 | G1 | G2 | G3 | G4 | G5 | |
| Gu | 26 (63.4) | 11 (26.8) | 4 (9.8) | / | / | / |
| Skin | 0 (0) | 10 (24.4) | 29 (70.7) | 2 (4.9) | / | / |
| Gi | 10 (24.4) | 17 (41.5) | 11 (26.8) | 3 (7.3) | / | / |
| Pain | 7 (17) | 22 (53.6) | 12 (29.4) | / | / | / |
| Hematological | 31 (75.6) | 4 (9.8) | 3 (7.3) | 2 (4.9) | / | 1 (2.4) |
- Citation: Belgioia L, Vagge S, Agnese D, Garelli S, Murialdo R, Fornarini G, Chiara S, Gallo F, Bacigalupo A, Corvò R. Intensified intensity-modulated radiotherapy in anal cancer with prevalent HPV p16 positivity. World J Gastroenterol 2015; 21(37): 10688-10696
- URL: https://www.wjgnet.com/1007-9327/full/v21/i37/10688.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i37.10688